The increase of optineurin (OPTN) alone can discriminate T2DM‐MCI from T2DM‐nMCI, and combination of the elevated platelet OPTN with rGSK‐3β has greatly increased the discriminating efficiency. The gene discussed is OPTN; the disease is type 2 diabetes mellitus.